RETRACTED ARTICLE: Preparation and characterization of novel lipid nanocapsules of ropivacaine for transdermal delivery

Reference

• Abdollahi M, Karimpour H, Monsef-Esfehani HR. (2003). Antinociceptive effects of Teucrium polium L. total extract and essential oil in mouse writhing test. Pharmacol Res 48:31–5
   PubMed Web of Science ®Google Scholar
• Åberg G. (1972). Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol Toxicol 31:273–86
   PubMedGoogle Scholar
• Albright GA. (1979). Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 51:285–7
   PubMed Web of Science ®Google Scholar
• Araujo DR, Cereda CMS, Brunetto GB. (2008). Pharmacological and local toxicity studies of a liposomal formulation for the novel local anaesthetic ropivacaine. J Pharm Pharmacol 60:1449–57
   PubMed Web of Science ®Google Scholar
• Barras A, Mezzetti A, Richard A. (2009). Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int J Pharm 379:270–7
   PubMed Web of Science ®Google Scholar
• Barry BW. (1987). Mode of action of penetration enhancers in human skin. J Control Release 6:85–97
   Google Scholar
• Bentley GA, Newton SH, Starr J. (1981). Evidence for an action of morphine and the enkephalins on sensory nerve endings in the mouse peritoneum. Br J Pharmacol 73:325–32
   PubMed Web of Science ®Google Scholar
• Chaykovska L, Blohmé L, Mayer D. (2014). Paraincisional subcutaneous infusion of ropivacaine after open abdominal vascular surgery shows significant advantages. Ann Vasc Surg 28:837–44
   PubMed Web of Science ®Google Scholar
• Chen S, Liu W, Wan J. (2013). Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique. Drug Dev Ind Pharm 39:20–8
   PubMed Web of Science ®Google Scholar
• Corrigan DO, Healy AM, Corrigan OI. (2003). The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials. Int J Pharm 262:125–37
   PubMed Web of Science ®Google Scholar
• Ding BY, Chen H, Wang C. (2013). Preparation and in vitro evaluation of apigenin loaded lipid nanocapsules. J Nanosci Nanotechnol 13:6546–52
   PubMed Web of Science ®Google Scholar
• Gené RM, Segura L, Adzet T. (1998). Heterotheca inuloides: Anti-inflammatory and analgesic effect. J Ethnopharmacol 60:157–162
   PubMed Web of Science ®Google Scholar
• Golshani S, Karamkhani F, Monsef-Esfehani HR. (2004). Antinociceptive effects of the essential oil of Dracocephalum kotschyi in the mouse writhing test. J Pharm Pharm Sci 7:76–9
   PubMed Web of Science ®Google Scholar
• Groban L. (2003). Central nervous system and cardiac effects from long-acting amide local anesthetic toxicity in the intact animal model. Reg Anesth Pain Med 28:3–11
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B. (2003a). The influence of lipid nanocapsule composition on their size distribution. Eur J Pharm Sci 18:55–61
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B. (2003b). Interfacial stability of lipid nanocapsules. Colloids Surf B Biointerfaces 30:225–35
   Web of Science ®Google Scholar
• Huynh NT, Passirani C, Saulnier P. (2009). Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 379:201–9
   PubMed Web of Science ®Google Scholar
• Jia LJ, Shen JY, Zhang DR. (2012). In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol 50:523–9
   PubMed Web of Science ®Google Scholar
• Joshi M, Patravale V. (2008). Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm 346:124–32
   PubMed Web of Science ®Google Scholar
• Kawadkar J, Pathak A, Kishore R. (2013). Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Drug Dev Ind Pharm 39:569–78
   PubMed Web of Science ®Google Scholar
• Lademann O, Kramer A, Richter H. (2011). Antisepsis of the follicular reservoir by treatment with tissue-tolerable plasma (TTP). Laser Phys Lett 8:313–17
   Web of Science ®Google Scholar
• Langley MS, Heel RC. (1988). Transdermal clonidine. Drugs 35:123–42
   PubMed Web of Science ®Google Scholar
• Leone S, Di Cianni S, Casati A. (2008). Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine. Acta Biomed 79:92–105
   PubMedGoogle Scholar
• Li X, Zhang Y, Fan Y. (2011). Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol. Nanoscale Res Lett 6:1–9
   Web of Science ®Google Scholar
• Luan JJ, Zhang DR, Hao LL. (2014). Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers. Colloids Surf B Biointerfaces 114:255–60
   PubMed Web of Science ®Google Scholar
• McClure J H. (1996). Ropivacaine. Br J Anaesth 76:300–7
   PubMed Web of Science ®Google Scholar
• Megrab NA, Williams AC, Barry BW. (1995). Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation. J Control Release 36:277–94
   Web of Science ®Google Scholar
• Mostafa DM, Ammar NM, Abd El-Alim SH. (2014). Transdermal microemulsions of Glycyrrhiza glabra L.: characterization, stability and evaluation of antioxidant potential. Drug Deliv 21:130–39
   PubMed Web of Science ®Google Scholar
• Perrier T, Saulnier P, Fouchet F. (2010). Post-insertion into lipid nanocapsules (LNCs): From experimental aspects to mechanisms. Int J Pharm 396:204–9
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Singal P. (2013). Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf B Biointerfaces 105:67–74
   PubMed Web of Science ®Google Scholar
• Segeren CM, Sonneveld P, Van Der Holt B. (1999). Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Br J Haematol 105:127–30
   PubMed Web of Science ®Google Scholar
• Senard M, Kaba A, Jacquemin MJ. (2004). Epidural levobupivacaine 0.1% or ropivacaine 0.1% combined with morphine provides comparable analgesia after abdominal surgery. Anesth Analg 98:389–94
   PubMed Web of Science ®Google Scholar
• Shen Y, Ji Y, Xu S. (2011). Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: Preparation, characterization, and pharmacokinetics. Drug Deliv 18:361–6
   PubMed Web of Science ®Google Scholar
• Simpson D, Curran MP, Oldfield V. Ropivacaine. (2005). Drugs 65:2675–717
   PubMed Web of Science ®Google Scholar
• Sinico C, Manconi M, Peppi M. (2005). Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle–skin interaction. J Control Release 103:123–36
   PubMed Web of Science ®Google Scholar
• Tan Q, Liu WD, Guo CY. (2011). Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. Int J Nanomedicine 6:1621–30
   PubMed Web of Science ®Google Scholar
• Tjølsen A, Hole K. (1997). Animal models of analgesia. In: Dickenson AH, Besson J-MR, eds. The pharmacology of pain. Berlin: Springer-Verlag 130:1–20
   Google Scholar
• Yamaguchi T, Kawai K, Yamanaka K. (2014). External preparation composition comprising fatty acid-based ionic liquid as active ingredient. U.S. Patent 8,623,387[P]. 2014-1-7.
   Google Scholar
• Zheng M, Falkeborg M, Zheng Y. (2013). Formulation and characterization of nanostructured lipid carriers containing a mixed lipids core. Colloids Surf A Physicochem Eng Asp 430:76–84
   Web of Science ®Google Scholar